Answer
Ceftriaxone sodium may increase oral anticoagulants’ anti-vitamin K effect and bleeding risk, so INR should be monitored frequently and the anti-vitamin K drug dose adjusted accordingly during and after ceftriaxone treatment.
Sources for this answer
- Rocephin 250mg Powder for Solution for Injection, 1g Powder for Solution for Injection or Infusion, 2g Powder for Solution for Injection/InfusionRoche Products Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 27Document updated
Sources checked